ID

36674

Description

Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02031601

Link

https://clinicaltrials.gov/show/NCT02031601

Keywords

  1. 5/31/19 5/31/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

May 31, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Small-Cell Lung Cancer NCT02031601

Eligibility Non-Small-Cell Lung Cancer NCT02031601

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
advanced (stage iiib/iv) non-small-cell lung cancer;
Description

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
although stageⅰ-ⅲa, have contraindications to surgery;
Description

TNM clinical staging | Contraindication to surgery

Data type

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C0852649
egfr mutation-positive (egfr exon-18, exon-19 or exon-21);
Description

EGFR gene mutation Positive | EGFR Exon 18 Mutation Positive | EGFR Exon 19 Mutation Positive | EGFR Exon 21 Mutation Positive

Data type

boolean

Alias
UMLS CUI [1,1]
C3266992
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C4289658
UMLS CUI [2,2]
C1514241
UMLS CUI [3,1]
C4289656
UMLS CUI [3,2]
C1514241
UMLS CUI [4,1]
C4289654
UMLS CUI [4,2]
C1514241
measurable disease;
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
ecog performance status 0 or 1 or 2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
wild-type egfr;
Description

EGFR Wild Type

Data type

boolean

Alias
UMLS CUI [1,1]
C1414313
UMLS CUI [1,2]
C1883559
prior exposure to agents directed at the her axis;
Description

Targeted Therapy HER Family Receptors

Data type

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C3812393
prior chemotherapy or systemic anti-tumor therapy after advanced disease;
Description

Prior Chemotherapy | Cancer treatment Systemic | Status post Advanced disease

Data type

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C0920425
UMLS CUI [2,2]
C0205373
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0679246
unstable systemic disease;
Description

Systemic disease Unstable

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0443343
any other malignancy within last 5 years, except cured basal cell cancer of skin or cured cancer in situ of cervix;
Description

Cancer Other | Exception Basal cell carcinoma Cured | Exception Carcinoma in situ of uterine cervix Cured

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1880198
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [3,3]
C1880198
brain metastasis or spinal cord compression.
Description

Metastatic malignant neoplasm to brain | Compression of spinal cord

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0037926

Similar models

Eligibility Non-Small-Cell Lung Cancer NCT02031601

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging
Item
advanced (stage iiib/iv) non-small-cell lung cancer;
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
TNM clinical staging | Contraindication to surgery
Item
although stageⅰ-ⅲa, have contraindications to surgery;
boolean
C3258246 (UMLS CUI [1])
C0852649 (UMLS CUI [2])
EGFR gene mutation Positive | EGFR Exon 18 Mutation Positive | EGFR Exon 19 Mutation Positive | EGFR Exon 21 Mutation Positive
Item
egfr mutation-positive (egfr exon-18, exon-19 or exon-21);
boolean
C3266992 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C4289658 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C4289656 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C4289654 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
Measurable Disease
Item
measurable disease;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0 or 1 or 2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
EGFR Wild Type
Item
wild-type egfr;
boolean
C1414313 (UMLS CUI [1,1])
C1883559 (UMLS CUI [1,2])
Targeted Therapy HER Family Receptors
Item
prior exposure to agents directed at the her axis;
boolean
C2985566 (UMLS CUI [1,1])
C3812393 (UMLS CUI [1,2])
Prior Chemotherapy | Cancer treatment Systemic | Status post Advanced disease
Item
prior chemotherapy or systemic anti-tumor therapy after advanced disease;
boolean
C1514457 (UMLS CUI [1])
C0920425 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0679246 (UMLS CUI [3,2])
Systemic disease Unstable
Item
unstable systemic disease;
boolean
C0442893 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Cancer Other | Exception Basal cell carcinoma Cured | Exception Carcinoma in situ of uterine cervix Cured
Item
any other malignancy within last 5 years, except cured basal cell cancer of skin or cured cancer in situ of cervix;
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain | Compression of spinal cord
Item
brain metastasis or spinal cord compression.
boolean
C0220650 (UMLS CUI [1])
C0037926 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial